Akebia Names New President and CEO
Akebia appoints new president and CEO.
Akebia Therapeutics, a biopharmaceutical company focused on developing and commercializing small molecules to treat anemia and other diseases, has appointed John P. Butler as its president and CEO. Butler was most recently CEO of Inspiration Biopharmaceuticals and prior to that, held several positions at Genzyme, including president of the Cardiometabolic and Renal Division. As CEO, Butler succeeds Joseph Gardner, PhD, who will remain as an advisor for Akebia and will continue in his role as CEO of the biopharmaceutical company Aerpio Therapeutics. The change will take effect Sept. 16, 2013. With Butler’s appointment, Akebia will establish a corporate office in the Boston area. Akebia's research and development office and activities will remain in Cincinnati.
Source: Akebia Therapeutics
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
